VIDEO: Reasons for lack of response to anti-VEGF therapy considered

Speaking at the Retina 2016 meeting, Sophie J. Bakri, MD, explores the question of whether patients who do not respond to anti-VEGF therapy for age-related macular degeneration are truly nonresponders or whether for these patients it is time to "revisit the diagnosis."